453 related articles for article (PubMed ID: 11149512)
1. Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NF-kappaB binding sites.
Saviano M; Romanelli A; Bucci E; Pedone C; Mischiati C; Bianchi N; Feriotto G; Borgatti M; Gambari R
J Biomol Struct Dyn; 2000 Dec; 18(3):353-62. PubMed ID: 11149512
[TBL] [Abstract][Full Text] [Related]
2. Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts.
Penolazzi L; Borgatti M; Lambertini E; Mischiati C; Finotti A; Romanelli A; Saviano M; Pedone C; Piva R; Gambari R
Int J Mol Med; 2004 Aug; 14(2):145-52. PubMed ID: 15254756
[TBL] [Abstract][Full Text] [Related]
3. Molecular interactions with nuclear factor kappaB (NF-kappaB) transcription factors of a PNA-DNA chimera mimicking NF-kappaB binding sites.
Romanelli A; Pedone C; Saviano M; Bianchi N; Borgatti M; Mischiati C; Gambari R
Eur J Biochem; 2001 Dec; 268(23):6066-75. PubMed ID: 11733000
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site.
Mischiati C; Borgatti M; Feriotto G; Rutigliano C; Breda L; Bianchi N; Gambari R
Int J Mol Med; 2002 Jun; 9(6):633-9. PubMed ID: 12011981
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the human NF-kappaB p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaB binding sites of the human immunodeficiency virus type 1 promoter.
Mischiati C; Borgatti M; Bianchi N; Rutigliano C; Tomassetti M; Feriotto G; Gambari R
J Biol Chem; 1999 Nov; 274(46):33114-22. PubMed ID: 10551882
[TBL] [Abstract][Full Text] [Related]
6. Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy.
Gambari R
Curr Med Chem; 2004 May; 11(10):1253-63. PubMed ID: 15134518
[TBL] [Abstract][Full Text] [Related]
7. Defining the peptide nucleic acids (PNA) length requirement for PNA binding-induced transcription and gene expression.
Wang G; Jing K; Balczon R; Xu X
J Mol Biol; 2001 Nov; 313(5):933-40. PubMed ID: 11700050
[TBL] [Abstract][Full Text] [Related]
8. An experimental study of mechanism and specificity of peptide nucleic acid (PNA) binding to duplex DNA.
Kuhn H; Demidov VV; Nielsen PE; Frank-Kamenetskii MD
J Mol Biol; 1999 Mar; 286(5):1337-45. PubMed ID: 10064701
[TBL] [Abstract][Full Text] [Related]
9. Extending recognition by peptide nucleic acids (PNAs): binding to duplex DNA and inhibition of transcription by tail-clamp PNA-peptide conjugates.
Kaihatsu K; Shah RH; Zhao X; Corey DR
Biochemistry; 2003 Dec; 42(47):13996-4003. PubMed ID: 14636068
[TBL] [Abstract][Full Text] [Related]
10. The influence of helix morphology on co-operative polyamide backbone conformational flexibility in peptide nucleic acid complexes.
Topham CM; Smith JC
J Mol Biol; 1999 Oct; 292(5):1017-38. PubMed ID: 10512700
[TBL] [Abstract][Full Text] [Related]
11. Peptide nucleic acids (PNA) and PNA-DNA chimeras: from high binding affinity towards biological function.
Uhlmann E
Biol Chem; 1998; 379(8-9):1045-52. PubMed ID: 9792437
[TBL] [Abstract][Full Text] [Related]
12. PNA-nitrogen mustard conjugates are effective suppressors of HER-2/neu and biological tools for recognition of PNA/DNA interactions.
Zhilina ZV; Ziemba AJ; Nielsen PE; Ebbinghaus SW
Bioconjug Chem; 2006; 17(1):214-22. PubMed ID: 16417271
[TBL] [Abstract][Full Text] [Related]
13. Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum.
Borgatti M; Romanelli A; Saviano M; Pedone C; Lampronti I; Breda L; Nastruzzi C; Bianchi N; Mischiati C; Gambari R
Oncol Res; 2003; 13(5):279-87. PubMed ID: 12688679
[TBL] [Abstract][Full Text] [Related]
14. Lysine-based peptide nucleic acids (PNAs) with strong chiral constraint: control of helix handedness and DNA binding by chirality.
Tedeschi T; Sforza S; Dossena A; Corradini R; Marchelli R
Chirality; 2005; 17 Suppl():S196-204. PubMed ID: 15952136
[TBL] [Abstract][Full Text] [Related]
15. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
Gambari R
Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
[TBL] [Abstract][Full Text] [Related]
16. Stability and transformations of bis-PNA/DNA triplex structural isomers.
Krupnik OV; Fadeeva NV; Kvitko N; Shepelev VA; Nielsen PE; Lazurkin YS
J Biomol Struct Dyn; 2004 Feb; 21(4):503-12. PubMed ID: 14692795
[TBL] [Abstract][Full Text] [Related]
17. Circular dichroism study of DNA binding by a potential anticancer peptide nucleic acid targeted against the MYCN oncogene.
Faccini A; Tortori A; Tedeschi T; Sforza S; Tonelli R; Pession A; Corradini R; Marchelli R
Chirality; 2008 Mar; 20(3-4):494-500. PubMed ID: 17963203
[TBL] [Abstract][Full Text] [Related]
18. Short pyrimidine stretches containing mixed base PNAs are versatile tools to induce translation elongation arrest and truncated protein synthesis.
Sénamaud-Beaufort C; Leforestier E; Saison-Behmoaras TE
Oligonucleotides; 2003; 13(6):465-78. PubMed ID: 15025913
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites.
Borgatti M; Lampronti I; Romanelli A; Pedone C; Saviano M; Bianchi N; Mischiati C; Gambari R
J Biol Chem; 2003 Feb; 278(9):7500-9. PubMed ID: 12446679
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulations of cyclohexyl modified peptide nucleic acids (PNA).
Sharma S; Sonavane UB; Joshi RR
J Biomol Struct Dyn; 2010 Apr; 27(5):663-76. PubMed ID: 20085383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
